Surgical Science Sweden AB
OTC:SUSRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
|
MBB SE
F:MBB
|
DE |
|
ON24 Inc
NYSE:ONTF
|
US |
|
Maxi-Cash Financial Services Corporation Ltd
SGX:5UF
|
SG |
|
H
|
Hock Lian Seng Holdings Ltd
SGX:J2T
|
SG |
|
Latrobe Magnesium Ltd
ASX:LMG
|
AU |
|
MineralRite Corp
OTC:RITE
|
US |
|
C
|
Climate Transition Capital Acquisition I BV
AEX:CTCA1
|
NL |
|
C
|
Cineplex Inc
F:CX0
|
CA |
|
E
|
Everyday People Financial Corp
XTSX:EPF
|
CA |
|
Riot Platforms Inc
F:AP4N
|
US |
|
Puma SE
F:PUMA
|
DE |
|
A
|
Absa Group Ltd
JSE:ABG
|
ZA |
|
O
|
Orient Electric Ltd
NSE:ORIENTELEC
|
IN |
|
Informa PLC
LSE:INF
|
UK |
Wall Street
Price Targets
SUSRF Price Targets Summary
Surgical Science Sweden AB
According to Wall Street analysts, the average 1-year price target for SUSRF is 5.54 USD with a low forecast of 3.54 USD and a high forecast of 8.09 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SUSRF's stock price target?
Price Target
5.54
USD
According to Wall Street analysts, the average 1-year price target for SUSRF is 5.54 USD with a low forecast of 3.54 USD and a high forecast of 8.09 USD.
What is Surgical Science Sweden AB's Revenue forecast?
Projected CAGR
10%
For the last 10 years the compound annual growth rate for Surgical Science Sweden AB's revenue is 36%. The projected CAGR for the next 3 years is 10%.
What is Surgical Science Sweden AB's Operating Income forecast?
Projected CAGR
63%
For the last 10 years the compound annual growth rate for Surgical Science Sweden AB's operating income is 44%. The projected CAGR for the next 3 years is 63%.
What is Surgical Science Sweden AB's Net Income forecast?
Projected CAGR
55%
For the last 10 years the compound annual growth rate for Surgical Science Sweden AB's net income is 45%. The projected CAGR for the next 3 years is 55%.
